Roswell Park to Test Investigational Brain Cancer Vaccine in Phase I…

Peptide vaccine targets cancer survival protein, putting tumor cells in Catch 22

(PRWeb September 27, 2012)

Read the full story at http://www.prweb.com/releases/2012/9/prweb9952006.htm